Columbia University

Technology Ventures

Gates Foundation Venture Capital Investing in the Biotech Startup Space

May 02, 2017
Speaker: 
Charlotte Hubbert
Faculty Club
Columbia University Medical Center
630 West 168th Street, Fourth Floor
New York, NY 10032
05:00pm

Join Columbia WIN for a discussion exploring venture capital investing in biotech companies with Charlotte Hubbert of The Bill & Melinda Gates Foundation. Charlotte brings a wealth of experience in venture capital investing, startups, and emerging biotechnology, having previously served as Vice President with H.I.G. BioVentures and an associate at Accelerator Corporation, where she was involved in the strategic development and management of many companies including Oncofactor, Groove Bipharma, and Acylin Therapeutics.

Following the presentation, there will be a networking reception with drinks and appetizers in the same location from 6 to 7 pm.


Dr. Charlotte Hubbert is a Partner with Gates Foundation Venture Capital, investing in innovative technologies that support The Bill & Melinda Gates Foundation initiatives in Global Health and Agriculture. Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics and medical devices at all stages of development. She was BOD observer at Cardeas Pharma and Alder Biopharmaceuticals. Charlotte started her career in early stage biotech investing at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing and managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development and management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex. Charlotte currently serves as an observer on the board of directors of Synlogic, Sera Prognostics, Lodo Therapeutics and Vir Biotechnology.

Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14).